Pharmacist-driven CGM Use in the Uninsured Population

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.

Key facts

Study ID

NCT03477838

Run by

Virginia Commonwealth University

People needed

28

Starts

2018-04-26

Expected to finish

2019-12-19

Last updated by the study team

2021-02-05

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult 18 years of age or older
• diagnosis of Type 1 or Type 2 diabetes
• A1c greater than 8%
• prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1 (GLP-1) receptor agonist

You may not qualify if…

• pregnant or breast-feeding
• on dialysis
• not appropriate for CGM use based on clinical judgment by the investigators
• patients with limited English proficiency

Where it is running

• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.